- Price
- $11.20
- Day
- +3.90%
- Mkt Cap
- $421.68M
- 52W Range
- $4.25 – $25.96
- Volume
- 2.35M
- Beta
- 0.93
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
BioAge Labs Inc. (NASDAQ:BIOA) stock plunged Friday after disappointing Phase 3 cardiovascular trial results from Novo Nordisk A/S (NYSE:NVO) sparked concerns about the potential of NLRP3-targeting therapies.
Read full article
BioAge Labs, Inc. (NASDAQ: BIOA - Get Free Report)'s stock price rose 5.5% on Friday. The stock traded as high as $23.09 and last traded at $23.3710. Approximately 51,852 shares changed hands during mid-day trading, a decline of 91% from the average daily volume of 609,561 shares. The stock had previously closed at $22.16. Analyst
Read full article